Clinical Features of Narcolepsy: Japanese Experiences

  • Y. Honda

Abstract

In this chapter, narcolepsy is discussed from the clinical point of view. Several areas of recent concern in research are described based on my personal experiences with Japanese narcoleptic patients. There is a large Japanese literature on narcolepsy which has not been known to the researchers of other countries because of the language barrier. Some of these studies are cited and explained briefly. First, the symptomatology associated with narcolepsy is discussed. This leads to the definition of the term “narcolepsy” and issues in the diagnostic criteria for narcolepsy and in differential diagnosis. Next, the pathophysiology of narcolepsy, neuroendocrine, neuropharmacological, and epidemiological findings are described, followed by recommendations of practical treatment plans and an introduction of the activities of the Japan Narcolepsy Association.

Keywords

Obesity Cortisol Schizophrenia Explosive Neurol 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adie WJ (1926) Idiopathic narcolepsy: a disease sui generis, with remarks on the mechanism of sleep. Brain 49: 257–306CrossRefGoogle Scholar
  2. Akimoto H, Honda Y, Takahashi Y (1960) Pharmacotherapy in narcolepsy. Dis Nerv Syst 21: 704–706PubMedGoogle Scholar
  3. Akimoto H, Nakakuki M, Honda Y, Takahashi Y, Toyoda J, Sasaki K, Machiyama T (1961) Clinical evaluation of the effect of central stimulants, MAO inhibitors, and imipramine in the treatment of affective disorders. Proceedings of the third world congress of psychiatry, Montreal, pp 958–963Google Scholar
  4. Asaka A (1981) Genetic markers and neuropsychiatric disorders (in Japanese). Jpn J Clin Psychiat [Rinsho Seishin Igaku] 10: 401–414Google Scholar
  5. Asaka A, Park K, Honda Y, Kuroiwa Y, Tsuji S, Hamaguchi H, Akizuki M, Matsumoto H, Omoto K (1981) Studies on genetic markers in intractable diseases. In: Watanabe I (ed) Annual report of Research Committee on Host Factors of Intractable Diseases, for the year 1980 (in Japanese). Ministry of Health and Welfare, Tokyo, pp 123–131Google Scholar
  6. Association of Sleep Disorders Centers and Association for the Psychophysiological Study of Sleep (1979) Diagnostic classification of sleep and arousal disorders. Sleep 2: 1–137Google Scholar
  7. Baraitser M, Parkes JD (1987) Genetic study of narcoleptic syndrome. J Med Genet 15: 254–259CrossRefGoogle Scholar
  8. Carskadon MA, Dement WC (1977) Sleep tendency: an objective measure of sleep loss. Sleep Res 6: 200Google Scholar
  9. Carskadon MA, Dement WC, Mitler MM, Roth T, Westbrook PR, Keenan S (1987) Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 9: 519–524Google Scholar
  10. Dement W, Zarcone V, Varner V, Hoddes E, Nassau S, Jacobs B, Brown J, McDonald A, Horan K, Glass R, Gonzales P, Friedman E, Phillips R (1972) The prevalence of narcolepsy. In: Chase MH, Stern WC, Walter PL (eds) Sleep research, vol.1. Brain Information Service/Brain Research Institute, UCLA, Los Angeles, p 148Google Scholar
  11. Edwards JH (1967) Familial predisposition in man. Br Med Bull 25: 58–64Google Scholar
  12. Falconer D (1965) The inheritance of liability to certain diseases estimated from the incidence among relatives. Ann Hum Genet 29: 51–76CrossRefGoogle Scholar
  13. Guilleminault C, Phillips R, Dement W (1975) A syndrome of hypersomnia with automatic behavior. Electroencephalogr Clin Neurophysiol 38: 403–413PubMedCrossRefGoogle Scholar
  14. Honda Y (1960) Clinical studies on the diencephalon-related psychic symptoms (in Japanese). Psychiatr Neurol Jpn 62: 297–325Google Scholar
  15. Honda Y (1972) Treatment of narcolepsy (in Japanese). In: Hirai T, Hara T, Hozaki H (eds) Treatments in psychiatry [Seishinka Chiryo-gaku]. Kanahara, Tokyo, pp 327–333Google Scholar
  16. Honda Y (1979) Census of narcolepsy, cataplexy and sleep life among teenagers in Fujisawa city. Sleep Res 8: 191Google Scholar
  17. Honda Y (1982 a) A trial of application of DSM-III diagnosis to narcoleptic patients with hallucinatory paranoid states (in Japanese). Jpn J Clin Psychiatry [Rinsho Seishin Igaku] 11: 239–246Google Scholar
  18. Honda Y (1982b) Narcolepsy and related hypersomnias. In: Ueda H, Shimazono Y, Takeuchi J, Toyokura Y (eds) Sleep disorders (in Japanese). Nankodo, Toyko, pp 199–224Google Scholar
  19. Honda Y (1982 c) Narcolepsy and its differential diagnosis from epilepsy (in Japanese). Neurol Med 16: 34–40Google Scholar
  20. Honda Y (1983) Activities of the Japan Narcolepsy Association (in Japanese). Jpn J Clin Psychiatry [Rinsho Seishin Igaku] 12: 1525–1530Google Scholar
  21. Honda Y, Hishikawa Y (1980) A long-term treatment of narcolepsy and excessive daytime sleepiness with pemoline (Betanamin). Curr Ther Res 27: 429–441Google Scholar
  22. Honda Y, Takahashi Y (1969) Clinical evaluation of some psychotropic drugs (lithium carbonate, pyrithioxine, chlomipramine) in narcolepsy (in Japanese). Annu Rep Pharmacopsychiatry Res Foundation 1: 56–60Google Scholar
  23. Honda Y, Takahashi Y (1971) Psychotic states observed during long-term administration of psychostimulants in narcolepsy (in Japanese). Annu Rep Pharmacopsychiatry Res Foundation 3: 164–169Google Scholar
  24. Honda Y, Takahashi Y, Suzuki J, Nishiyama A, Hosoki A, Ohno H, Furusawa Y, Nagatsuka K (1965) Psychic symptoms of narcoleptics, with special reference to their personality characteristics (in Japanese). Psychiatr Neurol Jpn [Seishin Shinkeigaku Zasshi] 67: 195Google Scholar
  25. Honda Y, Takahashi K, Takahashi S, Azumi K, Irie M et al. (1969) Growth hormone secretion during nocturnal sleep in normal subjects. J Clin Endocrinol Metab 29: 20–29PubMedCrossRefGoogle Scholar
  26. Honda Y, Hishikawa Y, Takahashi Y (1979) Long-term treatment of narcolepsy with methylphenidate (Ritalin). Curr Ther Res 25: 288–298Google Scholar
  27. Honda Y, Asaka A, Tanaka Y, Juji T (1983 a) Discrimination of narcoleptic patients by using genetic markers and HLA. Sleep Res 12: 254Google Scholar
  28. Honda Y, Asaka A, Tanimura M, Furusho T (1983 b) A genetic study of narcolepsy and excessive daytime sleepiness in 308 families with a narcolepsy or hypersomnia proband. In: Guilleminault C, Lugaresi E (eds) Sleep/wake disorders; natural history, epidemiology and long-term evolution. Raven, New York, pp 187–199Google Scholar
  29. Honda Y, Doi Y, Juji T, Satake M (1984) Narcolepsy and HLA: postive DR2 as a prerequisite for the development of narcolepsy. Folia Psychiatr Neurol Jpn 38: 360Google Scholar
  30. Honda Y, Juji T, Matsuki K, Naohara T, Satake M, Inoko H, Someya T, Harada S, Doi Y (1986 a) HLA-DR2 and Dw2 in narcolepsy and in other disorders of excessive somnolence without cataplexy. Sleep 9: 133–142PubMedGoogle Scholar
  31. Honda Y, Doi Y, Ninomiya R, Ninomiya C (1986 b) Increased frequency of non-insulin-dependent diabetes mellitus among narcoleptic patients. Sleep 9: 254–259PubMedGoogle Scholar
  32. Japan Narcolepsy Association (1979) Toward the better understanding of narcolepsy — invitation to the Japan Narcolepsy Association (Narco-Kai). Japan Narcolepsy Association, TokyoGoogle Scholar
  33. Kessler S (1975) Genetic factors in narcolepsy. In: Guilleminault WC, Dement C, Passouant P (eds) Narcolepsy. Spectrum, New York, pp 285–302Google Scholar
  34. Krüger J (1973) Zur Unterscheidung zwischen multifaktoriellem Erbgang mit Schwellenwerteffekt und einfachem diallelem Erbgang. Humangenetik 17: 181–252PubMedCrossRefGoogle Scholar
  35. Lhermitte J, Tournay A (1927) Le sommeil normal et pathologique. Rev Neurol (Paris) 1: 751–822;Google Scholar
  36. Maury A (1848) Des hallucinations hypnagogiques (ou des erreurs de sens). Ann Med Psychol II: 26–40Google Scholar
  37. Mitchell SW (1876) On some of the disorders of sleep. Virginia Med Monthly 2: 769–781Google Scholar
  38. Mitchell SW (1876) On some of the disorders of sleep. Virginia Med Monthly 2: 769–781Google Scholar
  39. Mitler MM, van den Hoed J, Carskadon MA et al. (1979) REM sleep episodes during the multiple sleep test in narcoleptic patients. EEG Clin Neurophysiol 46: 479–481CrossRefGoogle Scholar
  40. Nakagawa F, Saitoh Y, Kotaki H, Nakajima K, Honda Y (1986) Dosage adjustment of methylphenidate for patients with narcolepsy: determination of methylphenidate and its main metabolite in plasma by gas chromatography-chemical ionization mass spectrometry (in Japanese). Annu Rep Pharmacopsychiatry Res Foundation 17: 15–20Google Scholar
  41. Nakagawa Y (1980) Continuous observation of EEG patterns at night and in daytime of normal subjects under restrained conditions. I. Quiescent state when lying down. Electroencephalogr Clin Neurophysiol 49: 524–537PubMedCrossRefGoogle Scholar
  42. Nakajima K, Kotaki H, Saitoh Y, Nakagawa F (1986) Determination of methylphenidate and its main metabolite in plasma by gas chromatography-chemical ionization mass spectrometry. Chem Pharm Bull (Tokyo) 34: 1701–1708Google Scholar
  43. Nevsimalova-Bruhova S, Roth B (1972) Heredofamilial aspects of narcolepsy and hypersomnia. Arch Suisses Neurol Neurochir Psychiatr 110: 45–54Google Scholar
  44. Nishihara K, Kohda Y, Saitoh Y, Nakagawa F, Honda Y (1984) Determination of pemoline in plasma, plasma water, mixed salive, and urine by high-performance liquid chromatography. Ther Drug Monit 6: 232–237PubMedCrossRefGoogle Scholar
  45. Ohta T, Honda Y, Kameyama T, Kurita H, Takahashi Y (1980) A long-term prognosis of narcolepsy: 10–20 year follow-up study of patients diagnosed as narcolepsy during 1958–1969 (in Japanese). Jpn J Clin Psychiatr [Rinsho Seishin Igaku] 9: 485–493Google Scholar
  46. Penrose LS (1953) The genetical background of common diseases. Acta Genet 4: 257–265PubMedGoogle Scholar
  47. Rechtschaffen A, Wolpert W, Dement W, Mitchell S, Fischer C (1963) Nocturnal sleep of narcoleptics. Electroencephalogr Clin Neurophysiol 15: 599–609PubMedCrossRefGoogle Scholar
  48. Reich T, James J, Morris C (1972) The use of multiple thresholds in determining the mode of transmission of semi-continuous traits. Ann Hum Genet 36: 163–184PubMedCrossRefGoogle Scholar
  49. Richardson GS, Carskadon MA, Flagg W, van den Hoed J, Dement WC, Mitler MM (1978) Excessive daytime sleepiness in man: multiple sleep latency measurement in narcoleptic and control subjects. Electroencephalogr Clin Neurophysiol 45: 621–627PubMedCrossRefGoogle Scholar
  50. Rosenthal C (1928) Über die krankhaften Dissoziationszustände bei der echten Narkolepsie und dem verzögerten psychomotorischen Erwachen (Wachanfälle). Arch Psychiatr 84: 120–180CrossRefGoogle Scholar
  51. Rosenthal C (1939) Über das Auftreten von halluzinatorisch-kataplektischem Angstsyndrom, Wachanfällen und ähnlichen Störungen bei Schizophrenen. Monatsschr Psychiatr Neurol (Basel) 102: 11–38CrossRefGoogle Scholar
  52. Roth B (1962) Narkolepsie und Hypersomnie vom Standpunkt der Physiologie des Schlafes. VEB Verlag Volk und Gesundheit, BerlinGoogle Scholar
  53. Roth B (1980) Narcolepsy and hypersomnia. Karger, BaselGoogle Scholar
  54. Solomon P (1945) Narcolepsy in negroes. Dis Nerv Syst 6: 179–183Google Scholar
  55. Suzuki J (1966) Narcolepsy syndrome and paradoxical sleep. Folia Psychiatr Neurol Jpn 20: 123–149PubMedGoogle Scholar
  56. Takahashi K, Takahashi S, Azumi K, Honda Y, Utena H (1971) Changes of plasma growth hormone during nocturnal sleep in normals and in hypersomniac patients (in Japanese). Adv Neurol Sci [Shinkei Kenkyu-no Shimpo] 14: 743–754Google Scholar
  57. Takahashi Y (1977) Pathophysiology of narcolepsy (in Japanese). Clin Physiol [Rinsho-seiri] 7: 5–15Google Scholar
  58. Takahashi Y (1979) Growth hormone secretion related to the sleep and waking rhythm. In: Drucker-Colin R, Shkurovich M, Sterman MB (eds) The functions of sleep. Academic, New York, pp 113–145Google Scholar
  59. Takahashi Y, Honda Y (1964a) Pharmacotherapy in narcolepsy; part I: effects of central nervous system stimulants (in Japanese). Clin Psychiatry [Seishin Igaku] 6: 673–682Google Scholar
  60. Takahashi Y, Honda Y (1964b) Pharmacotherapy in narcolepsy; part II: effects of thymoleptics and other psychotropic drugs (in Japanese). Clin Psychiatry [Seishin Igaku] 6: 775–784Google Scholar
  61. Takahashi Y, Jimbo M (1963) Polygraphic study of narcoleptic syndrome with special reference to hypnagogic halucinations and cataplexy. Folia Psychiatr Neurol Jpn [Suppl] 7: 343–347Google Scholar
  62. Takahashi Y, Kipnis DM, Daughaday WH (1968) Growth hormone secretion during sleep. J Clin Invest 47: 2079–2090PubMedCrossRefGoogle Scholar
  63. Thomson G (1975) Narcolepsy: theoretical aspects of a genetic study. In: Guilleminault C, Dement WC, Passouant P (eds) Narcolepsy. Spectrum, New York, pp 303–310Google Scholar
  64. Thomson G (1985) The mode of inheritance of the HLA-linked gene predisposing to narcolepsy. Tissue Antigens 26: 201–203PubMedCrossRefGoogle Scholar
  65. Utena H, Honda Y, Takahashi S, Takahashi K (1968) Correlation between brain activities during sleep and humoral changes — time course of changes of plasma growth hormone and Cortisol levels during nocturnal sleep. In: Shimazono Y (ed) Annual Report of Research Committee on the Mechanism of Development of Disturbance of Consciousness, for the year 1967 (in Japanese). Ministry of Education, Science and Culture, TokyoGoogle Scholar
  66. Vogel G (1960) Studies in psychophysiology of dreams. III. The dream of narcolepsy. Arch Gen Psychiatry 3: 421–428PubMedGoogle Scholar
  67. Wilson R, Raynal D, Guilleminault C, Zarcon V, Dement W (1972) REM latencies in daytime sleep recordings of narcoleptics. Sleep Res 2: 166Google Scholar
  68. Wilson SAK (1928) The narcolepsies. Brain 51: 63–109CrossRefGoogle Scholar
  69. Yoss RE, Daly DD (1959) Treatment of narcolepsy with Ritalin. Neurology 9: 171–173PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • Y. Honda

There are no affiliations available

Personalised recommendations